TEL: 303-322-2254

Cytoskeleton, IncCytoskeleton, Inc
  • Cytoskeleton, Inc
  • Products
    • Featured New Product
    • Small G-protein Products
      • Small G-protein Activators & Inhibitors
      • Small G-protein Activation Assays
      • Small GTPase Affinity Beads
      • Small G-protein GEF/GAP and ELISA Kits
      • Small G-proteins
      • Modulator Proteins
      • Small G-protein Antibodies
      • Small G-protein Buffers
    • Post-Translational Modification (PTM) Products
      • Ubiquitination Tools
      • Acetyl-Lysine Tools
      • SUMOylation Tools
      • Phosphotyrosine Tools
      • Actin Oxidation Tools
      • Antibodies: PTMtrue™
      • Cell Lysis Tools
    • Tubulin & FtsZ Products
      • Tubulin Kits
      • Microtubules & Tubulin Proteins
      • Fluorescent and Labeled Tubulins
      • Microtubule-Associated Proteins (MAPs)
      • Live Cell Tubulin Reagents
      • Tubulin Antibodies
      • FtsZ Proteins
      • Tubulin Drugs and Buffers
    • Actin Products
      • Acti-stain™ Fluorescent Phalloidins
      • Actin Assays & Kits
      • Actin Proteins
      • Fluorescent and Labeled Actin
      • Actin Binding Proteins
      • Live Cell Actin Reagents
      • Actin Oxidation Tools
      • Actin Antibodies
      • Actin Drugs & Buffers
    • Live Cell Imaging Reagents
      • Live Cell Actin Reagents
      • Live Cell Tubulin Reagents
      • Small G-protein Activators & Inhibitors
      • Nuclear DNA Probes
      • Live Cell Membrane Probes
        • Plasma Membrane Probes
        • Membrane Tension Probes
        • Membrane Polarity Probes
      • Live Cell Mitochondrial Reagents
      • ECM Proteins
        • Fluorescent Fibronectin
        • Fluorescent Laminin
      • Live Cell Lipid Droplets
      • Other Organelles
      • Dyes/Substrates
    • ECM Proteins
      • Fluorescent Fibronectin
      • Fluorescent Laminin
    • Motor Protein Products
      • Motor Kits and Assays
      • Kinesin Proteins
      • Myosin Proteins
      • Dynein Proteins
      • Motor Protein Drugs & Buffers
    • General Protein Tools
      • Protein Quantitation
      • Cell Lysis Tools
      • ATPase & GTPase Assays
      • Other Protein Tools
    • GO-Blot V2 - Fully Automated And Programmable Western Blot Processor
  • Custom Services
    • All Services
    • Compound Screening
      • Tubulin Polymerization Assay Services
      • Kinesin ATPase Screening Services
      • Myosin ATPase Screening Services
      • GTP Exchange Factor (GEF) Assay Services
      • GTPase Activating Protein (GAP) Assay Services
      • FtsZ GTPase and Polymerization Assay Services
      • GTPase Activation Screening Services
    • Protein Purification
    • Assay Development
  • Resources
    • Resource Hub
      • Blogs
      • Videos
      • Protocols
      • Learning Documents
        • Ebook
    • FAQs
    • Datasheets and MSDS
  • About Us
    • About Us
    • Careers
    • Distributors
  • Contact Us
Your quote is empty.
Your cart is empty.
  1. Home
  2. Utilizing the BK128 kit to analyze Rac1 activity in zebrafish larvae and genetic variants of this organism as models of neuronal disease.

Utilizing the BK128 kit to analyze Rac1 activity in zebrafish larvae and genetic variants of this organism as models of neuronal disease.

Figure 1: Schematic showing zebrafish larvae which are about 5 mm long.

How does the Rac1 small GTPase contribute to neuropathological diseases?

The Ras-related C3 botulinum toxin substrate 1 (Rac1) protein is a well-studied member of the Rho GTPase family of small G-proteins. Like other small GTPases, Rac1 cycles between GTP- and GDP-bound states to function like a molecular switch in several critical signaling processes.

These Rac1-dependent signaling processes regulate many cellular processes, such as migration, through cytoskeleton-dependent mechanisms.Rac1-driven cellular processes are important in nearly all cell types, and dysfunction of Rac1 contributes to several diseases, most notably cancer(reviewed in 1).

While its role in cancer has garnered a significant amount of attention, Rac1 also plays a critical role in the brain and has been shown to regulate essential processes like intrinsic forgetting in memory2. Furthermore, it also contributes to neuronal development(reviewed in3), working memory4, and brain plasticity5.

Given its physiologic importance in the brain, it is not surprising to see that it has been implicated in several neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, Huntington’s disease, Alzheimer’s disease, and others(reviewed in 3).

Thus, having effective tools and experimental models to study Rac1 in the brain is essential to fully understand its role in neuropathology. Furthermore, as more Rac1-targeting therapeutics are uncovered6, it will be interesting to see how they affect Rac1 in the brain in neuropathological settings.

Figure 2: Schematic showing the steps needed to detect active Rac1 in zebrafish larvae extracts.
Why is the zebrafish model useful in studying neuropathological diseases?

Several models for studying neuropathological diseases exist, including mice, rats, zebrafish, Drosophila, C. elegans, and neuronal cell culture. The zebrafish model has become an essential tool for studying neuropathological processes and diseases due to its genetic resemblance to humans, as well as its similar neuroanatomical and neurochemical pathways.

Furthermore, general characteristics such as its rapid embryonic development, transparent larval stages allowing for efficient in vivo imaging, streamlined genetic manipulation, and utility for drug screening also make it a useful experimental model. Recent reviews highlight the utility of zebrafish models and their beneficial characteristics to study neuropathological processes7, 8.

Recently, Dulski et al.(9) investigated the role of Rac1 in brain connectivity impairments in a tuberous sclerosis complex (TSC) neurodevelopmental zebrafish model. Interestingly, they utilized both FRET and Rac1 G-LISA tools to analyze Rac1 activity in zebrafish larvae.

The FRET probe allowed investigators to measure live cell changes in Rac1 activity in the zebrafish brain. Complementary studies using the Rac1 G-LISA kit supported the FRET studies, while also enabling investigators to analyze the effects of Rac1 inhibitors in their model due to the faster processing time with this tool (see Figure 1).

The G-LISA data, in particular, was very promising as it's one of the first examples where this tool was used to analyze Rac1activity in zebrafish larvae9. When added to other examples where the Rac1 G-LISA was used to analyze Rac1 activity in mouse brain tissue10, 11 and neural progenitor cells12, it suggests that it may be an essential tool for neurobiologists studying Rac1.

References

1. Ma, N., et al., Rac1: A Regulator of Cell Migration and a Potential Target for Cancer Therapy. Molecules, 2023. 28(7).

2. Wang, W., et al., Roles of Rac1-Dependent Intrinsic Forgetting in Memory-Related Brain Disorders: Demon or Angel. Int J Mol Sci, 2023. 24(13).

3. Marei, H. and A. Malliri, Rac1 in human diseases: The therapeutic potential of targeting Rac1 signaling regulatory mechanisms. Small GTPases, 2017. 8(3): p. 139-163.

4. Kim, J., et al., Presynaptic Rac1 in the hippocampus selectively regulates working memory. Elife, 2024. 13.

5. Socodato, R., et al., Microglial Rac1 is essential for experience-dependent brain plasticity and cognitive performance. Cell Rep, 2023. 42(12): p. 113447.

6. Morstein, J., et al., Targeting Ras-, Rho-, and Rab-family GTPases via a conserved cryptic pocket. Cell, 2024. 187(22): p. 6379-6392 e17.

7. Chia, K., et al., Zebrafish as a model organism for neurodegenerative disease. Front Mol Neurosci, 2022. 15: p. 940484.

8. Chauhan, A., et al., Zebrafish models for neurological disorders: a platform for natural product-based drug discovery. Frontiers in Natural Products, 2026. Volume 4 - 2025.

9. Dulski, T., O. Doszyń, and J. Zmorzyńska, Rac1 contributes to brain connectivity impairments and neuropsychiatric disorders in Tuberous Sclerosis Complex. bioRxiv, 2025: p. 2025.12.09.693152.

10. Haq, N., et al., Loss of Bardet-Biedl syndrome proteins causes synaptic aberrations in principal neurons. PLoS Biol, 2019. 17(9): p. e3000414.

11. Ishchenko, Y., et al., Heterozygosity for neurodevelopmental disorder-associated TRIO variants yields distinct deficits in behavior, neuronal development, and synaptic transmission in mice. Elife, 2025. 13.

12. Wegscheid, M.L., et al., Patient-derived iPSC-cerebral organoid modeling of the 17q11.2 microdeletion syndrome establishes CRLF3 as a critical regulator of neurogenesis. Cell Rep, 2021. 36(1): p. 109315.

Cytoskeleton, Inc
Contact UsMy Account

Tel: 303-322-2254

  • Blogs
  • FAQ's
  • Datasheets and MSDS
  • Protocols
  • Learning Documents
  • Videos
  • About Us
  • Careers
  • Distributors
  • Terms of Service and Policy Info
  • All Services
  • Compound Screening
  • Protein Purification
  • Assay Development
  • Post-Translational Modification (PTM) Tools
  • Motor Protein Products
  • Live Cell Imaging Reagents
  • Actin Products
  • ECM Proteins
  • Small G-protein Products
  • Tubulin & FtsZ Products
  • General Protein Tools
Linkedin

© 2026 Cytoskeleton, Inc All Rights Reserved.

Privacy Policy
Log in to your Account